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Abstract
Genetic differences between individuals associated to quantitative phenotypic traits,
including disease states, are usually found in non-coding genomic regions. These ge-
netic variants are often also associated to differences in expression levels of nearby genes
(they are “expression quantitative trait loci” or eQTLs, for short) and presumably play
a gene regulatory role, affecting the status of molecular networks of interacting genes,
proteins and metabolites. Computational systems biology approaches to reconstruct
causal gene networks from large-scale omics data have therefore become essential to
understand the structure of networks controlled by eQTLs together with other regula-
tory genes, as well as to generate detailed hypotheses about the molecular mechanisms
that lead from genotype to phenotype. Here we review the main analytical methods and
softwares to identify eQTLs and their associated genes, to reconstruct co-expression net-
works and modules, to reconstruct causal Bayesian gene and module networks, and to
validate predicted networks in silico.
Contents
1 Introduction 2
2 Genetics of gene expression 4
3 Co-expression networks and modules 6
3.1 Co-expression gene networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3.2 Clustering and co-expression module detection . . . . . . . . . . . . . . . . . . 7
4 Causal gene networks 10
4.1 Using genotype data to prioritize edge directions in co-expression networks . 10
4.2 Using Bayesian networks to identify causal regulatory mechanisms . . . . . . 11
4.3 Using module networks to identify causal regulatory mechanisms . . . . . . . 13
4.4 Illustrative example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1
ar
X
iv
:1
51
2.
05
57
4v
2 
 [q
-b
io.
M
N]
  1
 N
ov
 20
16
5 In silico validation of predicted gene regulation networks 14
6 Future perspective: Integration of multi-omics data 17
7 Conclusions 17
1 Introduction
Genetic differences between individuals are responsible for variation in the observable phe-
notypes. This principle underpins genome-wide association studies (GWAS), which map
the genetic architecture of complex traits by measuring genetic variation at single-nucleotide
polymorphisms (SNPs) on a genome-wide scale across many individuals [1]. GWAS have
resulted in major improvements in plant and animal breeding [2] and in numerous insights
into the genetic basis of complex diseases in human [3]. However, quantitative trait loci
(QTLs) with large effects are uncommon and a molecular explanation for their trait associ-
ation rarely exists [1]. The vast majority of QTLs indeed lie in non-coding genomic regions
and presumably play a gene regulatory role [4, 5]. Consequently, numerous studies have
identified cis- and trans-acting DNA variants that influence gene expression levels (i.e., “ex-
pression QTLs”; eQTLs) in model organisms, plants, farm animals and human (reviewed
in [6–10]). Gene expression programmes are of course highly tissue- and cell-type specific,
and the properties and complex relations of eQTL associations across multiple tissues are
only beginning to be mapped [11–14]. At the molecular level, a mounting body of evidence
shows that cis-eQTLs primarily cause variation in transcription factor (TF) binding to gene
regulatory DNA elements, which then causes changes in histone modifications, DNA methy-
lation and mRNA expression of nearby genes; trans-eQTLs in turn can usually be attributed
to coding variants in regulatory genes or cis-eQTLs of such genes [15].
Taken together, these results motivate and justify a systems biological view of quantitative
genetics (“systems genetics”), where it is hypothesized that genetic variation, together with
environmental perturbations, affects the status of molecular networks of interacting genes,
proteins and metabolites; these networks act within and across different tissues and collec-
tively control physiological phenotypes [16–22]. Studying the impact of genetic variation on
gene regulation networks is of crucial importance in understanding the fundamental bio-
logical mechanisms by which genetic variation causes variation in phenotypes [23], and is
expected to lead to the discovery of novel disease biomarkers and drug targets in human
and veterinary medicine [24]. Since direct experimental mapping of genetic, protein–protein
or protein–DNA interactions is an immensely challenging task, further exacerbated by the
cell-type specific and dynamic nature of these interactions [25], comprehensive, experimen-
tally verified molecular networks will not become available for multi-cellular organisms in
the foreseeable future. Statistical and computational methods are therefore essential to re-
construct trait-associated causal networks by integrating diverse omics data [18, 19, 26].
A typical systems genetics study collects genotype and gene, protein and/or metabolite ex-
pression data from a large number of individuals segregating for one or more traits of in-
terest. After raw data processing and normalization, eQTLs are identified for each of the
expression data types, and a co-expression matrix is constructed. Causal Bayesian gene net-
works, co-expression modules (i.e. clusters) and/or causal Bayesian module networks are
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Figure 1: A flow chart for a typical systems genetics study and the corresponding softwares.
Steps in light yellow are covered in this chapter.
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then reconstructed. In silico validation of predicted networks and modules using indepen-
dent data confirms their overall validity, ideally followed by experimental validation of the
most promising findings in a relevant cell line or model organism (Figure 1). Here we re-
view the main analytic principles behind each of the steps from eQTL identification to in
silico network validation, and present a selection of most commonly used methods and soft-
wares for each step. Throughout this chapter, we tacitly assume that all data has been quality
controlled, pre-processed and normalized to suit the assumptions of the analytic methods
presented here. For expression data, this usually means working with log-transformed data
where each gene expression profile is centred around zero with standard deviation one. We
also assume that the data has been corrected for any confounding factors, either by regress-
ing out known covariates and/or by estimating hidden factors [27].
2 Genetics of gene expression
A first step towards identifying molecular networks affected by DNA variants is to iden-
tify variants that underpin variations in eQTLs of transcripts [8], proteins [28] or metabo-
lites [29] across individuals. When studying a single trait, as in GWAS, it is possible to
consider multiple statistical models to explicitly account for additive and/or dominant ge-
netic effects [30]. However, when the possible effects of a million or more SNPs on tens of
thousands of molecular abundance traits need to be tested, as is common in modern ge-
netics of gene expression studies, the computational cost of testing SNP-trait associations
one-by-one becomes prohibitive. To address this problem, new methods have been de-
veloped to calculate the test statistics for the parametric linear regression and analysis of
variance (ANOVA) models [31] and the non-parametric ANOVA model (or Kruskal-Wallis
test) [32] using fast matrix multiplication algorithms, implemented in the softwares matrix-
eQTL (http://www.bios.unc.edu/research/genomic_software/Matrix_eQTL/) [31] and
kruX (https://github.com/tmichoel/krux) [32].
In both softwares, genotype values of s genetic markers and expression levels of k transcripts,
proteins or metabolites in n individuals are organized in an s× n genotype matrix G and k×
n expression data matrix X. Genetic markers take values 0, 1, . . . , `, where ` is the maximum
number of alleles (` = 2 for biallelic markers), while molecular traits take continuous values.
In the linear model, a linear relation is tested between the expression level of gene i and the
genotype value (i.e. the number of reference alleles) of SNP j. The corresponding test statistic
is the Pearson correlation between the ith row of X and the jth row of G, for all values of i
and j. Standardising the data matrices to zero mean and unit variance, such that for all i and
j,
n
∑
l=1
Xil =
n
∑
l=1
Gjl = 0 and
n
∑
l=1
X2il =
n
∑
l=1
G2jl = n,
it follows that the correlation values can be computed as
Rij =
n
∑
l=1
XilGjl = (XGT)ij,
where GT denotes the transpose of G. Hence, a single matrix multiplication suffices to com-
pute the test statistics for the linear model for all pairs of traits and SNPs.
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The ANOVA models test if expression levels in different genotype groups originate from the
same distribution. Therefore, ANOVA models can account for both additive and dominant
effects of a genetic variant on expression levels. In the parametric ANOVA model, suppose
the test samples are divided into `+ 1 groups by the SNP j. The mean expression level for
gene i in each group m can be written as
X(m,j)i =
1
n(m,j) ∑{l : Gjl=m}
Xil ,
where n(m,j) is the number of samples in genotype group m for SNP j.
Again assuming that the expression data is standardised, the F-test statistic for testing gene
i against SNP j can be written as
F(j)i =
n− `− 1
`
SS(j)i
n− SS(j)i
,
where SS(j)i is the sum of squares between groups,
SS(j)i =
`
∑
m=0
n(m,j)X(m,j)i
2
.
Let us define the n× s indicator matrix I(m) for genotype group m, i.e. I(m)l j = 1 if Gjl = m
and 0 otherwise. Then
∑
{l : Gjl=m}
Xil =
(
XI(m)
)
ij
.
Hence, for each pair of expression level Xi and SNP Gj, the sum of squares matrix SS
(j)
i can
be computed via `− 1 matrix multiplications 1.
In the non-parametric ANOVA model, the expression data matrix is converted to a matrix
T of data ranks, independently over each row. In the absence of ties, the Kruskal-Wallis test
statistic is given by
Sij =
12
n(n + 1)
`
∑
m=0
n(m,j) T(m,j)i
2
− 3(n + 1),
where T(m,j)i is the average expression rank of gene i in genotype group m of SNP j, defined
as
T(m,j)i =
1
n(m,j) ∑{l : Gjl=m}
Til ,
which can be similarly obtained from the `− 1 matrix multiplications.
1There are only ` − 1 matrix multiplications, because the data standardization implies that XI(0) = 1 −
∑`−1m=1 XI
(m).
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There is as yet no consensus about which statistical model is most appropriate for eQTL
detection. Non-parametric methods were introduced in the earliest eQTL studies [33, 34]
and have remained popular, as they are robust against variations in the underlying genetic
model and trait distribution. More recently, the linear model implemented in matrix-eQTL
has been used in a number of large-scale studies [14, 35]. A comparison on a dataset of 102
human whole blood samples showed that the parametric ANOVA method was highly sen-
sitive to the presence of outlying gene expression values and SNPs with singleton genotype
group. Linear models reported the highest number of eQTL associations after empirical
False Discovery Rate (FDR) correction, with an expected bias towards additive linear asso-
ciations. The Kruskal-Wallis test was most robust against data outliers and heterogeneous
genotype group sizes and detected a higher proportion of non-linear associations, but was
more conservative for calling additive linear associations than linear models [32].
In summary, when large numbers of traits and markers have to be tested for association, ef-
ficient matrix multiplication methods can be employed to calculate all test statistics at once,
leading to a dramatic reduction in computation time compared to calculating these statistics
one-by-one for every pair using traditional methods. Matrix multiplication is a basic math-
ematical operation which has been purposely studied and optimized for tens of years [36].
Highly efficient packages, such as BLAS (http://www.netlib.org/blas/) and LAPACK
(http://www.netlib.org/lapack/), are available for use on generic CPUs, and are indeed
employed in most mainstream scientific computing softwares and programming languages,
such as Matlab and R. In recent years, Graphics Processor Unit (GPU)-accelerated comput-
ing, such as CUDA, has revolutionised scientific calculations that involve repetitive oper-
ations in parallel on bulky data, offering even more speedup than the existing CPU-based
packages. The first applications of GPU computing in eQTL analysis have already appeared
(e.g. [37]), and more can be expected in the future.
Lastly, for pairs exceeding a pre-defined threshold on the test statistic, a p-value can be com-
puted from the corresponding test distribution, and these p-values can then be further cor-
rected for multiple testing by common procedures [31, 32].
3 Co-expression networks and modules
3.1 Co-expression gene networks
The Pearson correlation is the simplest and computationally most efficient similarity mea-
sure for gene expression profiles. For genes i and j, their Pearson correlation can be written
as
Cij =
n
∑
l=1
XilXjl . (1)
In matrix notation, this can be combined as the matrix multiplication
C = XXT.
Gene pairs with large positive or negative correlation values tend to be up- or down-regulated
together, due to either a direct regulatory link between them, or being jointly co-regulated
by a third, often hidden, factor. By filtering for correlation values exceeding a significance
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threshold determined by comparison with randomly permuted data, a discrete co-expression
network is obtained. Assuming that a high degree of co-expression signifies that genes are
involved in the same biological processes, graph theoretical methods can be employed, for
instance, to predict gene function [38].
One drawback of the Pearson correlation is that by definition it is biased towards linear
associations. To overcome this limitation, other measures are available. The Spearman cor-
relation uses expression data ranks (cf. Section 2) in Equation (1), and will give high score
to monotonic relations. Mutual information is the most general measure and detects both
linear and non-linear associations. For a pair of discrete random variables A and B (repre-
senting the expression levels of two genes) taking values al and bm, respectively, the mutual
information is defined as
MI(A, B) = H(A) + H(B)− H(A, B),
where
H(A) = −∑
l
P(al) log P(al),
H(B) = −∑
m
P(bm) log P(bm),
H(A, B) =∑
lm
P(al , bm) log P(al , bm),
are the individual and joint Shannon entropies of A and B, and P(al) = P(A = al), and like-
wise for the other terms. Since gene expression data are continuous, mutual information esti-
mation is non-trivial and usually involves some form of discretisation [39]. Mutual informa-
tion has been successfully used as a co-expression measure in a variety of contexts [40–42].
3.2 Clustering and co-expression module detection
It is generally understood that cellular functions are carried out by “modules”, groups of
molecules that operate together and whose function is separable from that of other mod-
ules [43]. Clustering gene expression data (i.e. dividing genes into discrete groups on the
basis of similarities in their expression profiles) is a standard approach to detect such func-
tionally coherent gene modules. The literature on gene expression clustering is vast and
cannot possibly be reviewed comprehensively here. It includes “standard” methods such
as hierarchical clustering [44], k-means [45], graph-based methods that operate directly on
co-expression networks [46], and model-based clustering algorithms which assume that the
data is generated by a mixture of probability distributions, one for each cluster [47]. Here
we briefly describe a few recently developed methods with readily available softwares.
Modularity maximization Modularity maximization is a network clustering method that
is particularly popular in the physical and social sciences, based on the assumption that
intra-module connectivity should be much denser than inter-module connectivity [48, 49].
In the context of co-expression networks, this method can be used to identify gene modules
directly from the correlation matrix C [50]. Suppose the genes are grouped into N modules
Ml , l = 1, . . . , N. Each module Ml is a non-empty set that can contain any combination of
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the genes i = 1, . . . , k, but each gene is contained by exactly one module. Also define M0 as
the set containing all genes. The modularity score function is defined as
S(M) =
N
∑
l=1
(
W(Ml , Ml)
W(M0, M0)
−
(
W(Ml , M0)
W(M0, M0)
)2)
,
where W(A, B) = ∑i∈A,j∈B,i 6=j w(Cij) is a weight function, summing over all the edges that
connect one vertex in A with another vertex in B, and w(x) is a monotonic function to map
correlation values to edge strengths. Common functions are w(x) = |x|, |x|β (power law)
[51], eβ|x| (exponential) [50], or 1/(1 + eβx) (sigmoid) [52].
A modularity maximization software particularly suited for large networks is Fast Modu-
larity (http://www.cs.unm.edu/~aaron/research/fastmodularity.htm) [53].
Markov Cluster algorithm The Markov Cluster (MCL) algorithm is a graph-based clus-
tering algorithm, which emulates random walks among gene vertices to detect clusters in a
graph obtained directly from the co-expression matrix C. It is implemented in the MCL soft-
ware (http://micans.org/mcl/) [54,55]. The MCL algorithm starts with the correlation ma-
trix C as the probability flow matrix of a random walk, and then iteratively suppresses weak
structures of the network and performs a multi-step random walk. In the end, only back-
bones of the network structure remain, essentially capturing the modules of co-expression
network. To be precise, the MCL algorithm performs the following two operations on C
alternatingly:
• Inflation: The algorithm first contrasts stronger direct connections against weaker
ones, using an element-wise power law transformation, and normalizes each column
separately to sum to one, such that the element Cij corresponds to the dissipation
rate from vertex Xi to Xj in a single step. The inflation operation hence updates C
as C→ ΓαC, where the contrast rate α > 1 is a predefined parameter of the algorithm.
After operation Γα, each element of C becomes
Cij → ΓαCij = |Cij|α/
k
∑
p=1
|Cpj|α.
• Expansion: The probability flow matrix C controls the random walks performed in
the expansion phase. After some integer β ≥ 2 steps of random walk, gene pairs with
strong direct connections and/or strong indirect connections through other genes tend
to see more probability flow exchanges, suggesting higher probabilities of belonging
to the same gene modules. The expansion operation for the β-step random walk cor-
responds to the matrix power operation
C→ Cβ.
The MCL algorithm performs the above two operations iteratively until convergence. Non-
zero entries in the convergent matrix C connect gene pairs belonging to the same cluster,
whereas all inter-cluster edges attain the value zero, so that cluster structure can be obtained
directly from this matrix [54, 55].
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Weighted Gene Co-expression Network Analysis With higher than average correlation or
edge densities within clusters, genes from the same cluster typically share more neighbour-
ing (i.e. correlated) genes. The weighted number of shared neighbouring genes hence can
be another measure of gene function similarity. This information is captured in the so-called
topological overlap matrix Ω, first defined in [56] for binary networks as
ωij =
Aij +∑u Aiu Auj
min(ki, k j) + 1− Aij ,
where A is the (binary) adjacency matrix of the network and ki = ∑u Aiu is the connectivity
of vertex Xi. The ∑u Aiu Auj term represents vertex similarity through neighbouring genes,
and the rest of terms normalise the output as 0 ≤ ωij ≤ 1. This concept was later extended
onto networks with weighted edges by applying a “soft threshold” pre-process on the cor-
relation matrix, for example as
Aij =
∣∣∣∣1 + Cij2
∣∣∣∣α ,
or
Aij =
∣∣Cij∣∣α ,
such that 0 ≤ Aij ≤ 1 [57]. Note that in the first case only positive correlations have
high edge weight, whereas in the second case positive and negative correlations are treated
equally. The parameter α > 1 is determined such that the weighted network with adjacency
matrix A has approximately a scale-free degree distribution [57].
In principle, any clustering algorithm (including the aforementioned ones) can be applied to
the topological overlap matrixΩ. In the popular WGCNA software (http://labs.genetics.
ucla.edu/horvath/htdocs/CoexpressionNetwork/Rpackages/WGCNA/) [51], which is a multi-
purpose toolbox for network analysis, hierachical clustering with a dynamic tree-cut algo-
rithm [58] is employed.
Model-based clustering Model-based clustering approaches assume that the observed data
is generated by a mixture of probability distributions, one for each cluster, and takes explic-
itly into account the noise of gene expression data. To infer model parameters and clus-
ter assignments, techniques such as Expectation Maximization (EM) or Gibbs sampling are
used [59]. A recently developed method assumes that the expression levels of genes in a
cluster are random samples drawn from a mixture of normal distributions, where each mix-
ture component corresponds to a clustering of samples for that module, i.e. it performs a
two-way co-clustering operation [60]. The method is available as part of the Lemon-Tree
package (https://github.com/eb00/lemon-tree) and has been successfully used in a va-
riety of applications [61].
The co-clustering is carried out by a Gibbs sampler which iteratively updates the assignment
of each gene and, within each gene cluster, the assignment of each experimental condition.
The co-clustering operation results the full posterior distribution, which can be written as
p(C | X) ∝
N
∏
l=1
Ll
∏
u=1
∫∫
p(µ, τ) ∏
i∈Ml
∏
m∈El,u
p(Xim | µ, τ) dµdτ,
9
where C = {Ml , El,u : l = 1, . . . , N; u = 1, . . . , Ll} is a co-clustering consisting of N gene
modules Ml , each of which has a set of Lm sample clusters as El,u; p(Xim | µ, τ) is a normal
distribution function with mean µ and precision τ; and p(µ, τ) is a non-informative normal-
gamma prior. Detailed investigations of the convergence properties of the Gibbs sampler
showed that the best results are obtained by deriving consensus clusters from multiple inde-
pendent runs of the sampler. In the Lemon-Tree package, consensus clustering is performed
by a novel spectral graph clustering algorithm [62] applied to the weighted graph of pair-
wise frequencies with which two genes are assigned to the same gene module [61].
4 Causal gene networks
4.1 Using genotype data to prioritize edge directions in co-expression networks
Pairwise correlations between gene expression traits define undirected co-expression net-
works. Several studies have shown that pairs of gene expression traits can be causally or-
dered using genotype data [63–69]. Although varying in their statistical details, these meth-
ods conclude that gene A is causal for gene B, if expression of B associates significantly with
A’s eQTLs and this association is abolished by conditioning on expression of A and on any
other known confounding factors. In essence, this is the principle of “Mendelian random-
ization”, first introduced in epidemiology as an experimental design to detect causal effects
of environmental exposures on human health [70], applied to gene expression traits.
To illustrate how these methods work, let A and B be two random variables representing
two gene expression traits, and let E be a random variable representing a SNP which is an
eQTL for gene A and B. Since genotype cannot be altered by gene expression (i.e. E cannot
have any incoming edges), there are three possible regulatory models to explain the joint
association of E to A and B:
1. E → A → B: the association of E to B is indirect and due to a causal interaction from
A to B.
2. E→ B→ A: idem with the roles of A and B reversed.
3. A← E→ B: A and B are independently associated to E.
To determine if gene A mediates the effect of SNP E on gene B (model 1), one can test
whether conditioning on A abolishes the correlation between E and B, using the partial
correlation coefficient
cor(E, B | A) = cor(E, B)− cor(E, A)cor(B, A)√
(1− cor(E, A)2)(1− cor(B, A)2).
If model 1 is correct, then cor(E, B | A) is expected to be zero, and this can be tested for exam-
ple using Fisher’s Z transform to assess the significance of a sample correlation coefficient.
The same approach can be used to test model 2, and if neither is significant, it is concluded
that no inference on the causal direction between A and B can be made (using SNP E), i.e.
that model 3 is correct. For more details, see [65], who have implemented this approach in
the NEO software (http://labs.genetics.ucla.edu/horvath/htdocs/aten/NEO/).
10
Other approaches are based on the same principle, but use statistical model selection to
identify the most likely causal model, with the probability density functions (PDF) for the
models below:
• p(E, A, B) = p(E)p(A | E)p(B | A),
• p(E, A, B) = p(E)p(B | E)p(A | B),
• p(E, A, B) = p(E)p(A | E)p(B | E, A),
where the dependence on A in the last term of the last model indicates that there may be
a residual correlation between B and A not explained by E. The minimal additive model
assumes the distributions are [66]
E ∼ Bernoulli(q),
A | E ∼ N(µA|E, σ2A),
B | A ∼ N
(
µB + ρ
σB
σA
(A− µA), (1− ρ2)σ2B
)
,
B | E, A ∼ N
(
µB|E + ρ
σB
σA
(A− µA|E), (1− ρ2)σ2B
)
,
so that E fulfills a Bernoulli distribution, A | E undergoes a normal distribution whose
mean depends on E, and that B | A has a conditional normal distribution whose mean and
variance are contributed in part by A. For (B | E, A), the mean of B also depends on E.
The parameters of all distributions can be estimated by maximum likelihood, and the model
with the highest likelihood is selected as the most likely causal model. The number of free
parameters can be accounted using penalties like the Akaike information criterion (AIC) [66].
The approach has been extended in various ways. In [64], likelihood ratio tests, compar-
ison to randomly permuted data, and false discovery rate estimation techniques are used
to convert the three model scores in a single probability value P(A → B) for a causal
interaction from gene A to B. This method is available in the Trigger software (https:
//www.bioconductor.org/packages/release/bioc/html/trigger.html). In [69] and [68],
the model selection task is recast into a single hypothesis test, using F-tests and Vuong’s
model selection test respectively, resulting in a significance p-value for each gene-gene causal
interaction.
It should be noted that all of the above approaches suffer from limitations due to their inher-
ent model assumptions. In particular, the presence of unequal levels of measurement noise
among genes, or of hidden regulatory factors causing additional correlation among genes,
can confuse causal inference. For example, excessive error level in the expression data of
gene A, may mistake the true structure E → A → B as E → B → A. These limitations are
discussed in [18, 71].
4.2 Using Bayesian networks to identify causal regulatory mechanisms
Bayesian networks are probabilistic graphical models which encode conditional dependen-
cies between random variables in a directed acyclic graph (DAG). Although Bayesian net-
work cannot fully reflect certain pathways in gene regulation, such as self-regulation or feed-
back loops, they still serve as a popular method for modelling gene regulation networks, as
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they provide a clear methodology for learning statistical dependency structures from possi-
bly noisy data [72–74].
We adopt our previous convention in Section 2, where we have the gene expression data
X and genetic markers G. The model contains a total of k vertices (i.e. random variables),
Xi with i = 1, . . . , k, corresponding to the expression level of gene i. Given a DAG G, and
denoting the parental vertex set of Xi by Pa(G)(Xi), the acyclic property of G allows to define
the joint probability distribution function as
p(X1, . . . , Xk | G) =
k
∏
i=1
p(Xi | Pa(G)(Xi)). (2)
In its simplest form, we model the conditional distributions as
p
(
Xi | Pa(G)(Xi)
)
= N
(
αi + ∑
Xj∈Pa(G)(Xi)
β ji(Xj − αj), σ2i
)
,
where (αi, σi) and β ji are parameters for vertex Xi and edge Xj → Xi respectively, as part
of the DAG structure G. Under such modelling, the Bayesian network is called a linear
Gaussian network.
The likelihood of data X given the graph G is
p(X | G) =
k
∏
i=1
n
∏
l=1
p(Xil | {Xjl , Xj ∈ Pa(G)(Xi)}).
Using Bayes’ rule, the log-likelihood of the DAG G based on the gene expression data X
becomes
log p(G | X) = log p(X | G) + log p(G)− log p(X),
where p(G) is the prior probability for G, and p(X) is a constant when the expression data is
provided, so the follow-up calculations do not rely on it.
Typically, a locally optimal DAG is found by starting from a random graph and randomly
ascending the likelihood by adding, modifying, or removing one directed edge at a time
[72–74]. Alternatively, the posterior distribution p(G | X) can be estimated with Bayesian
inference using Markov Chain Monte Carlo (MCMC) simulation, allowing us to estimate
the significance levels at an extra computational cost. The parameter values of α, β, and σ,
as part of G, can be estimated with maximum likelihood.
When Bayesian network is modified by a single edge, only the vertices that receive a change
would require a recalculation, whilst all others remain intact. This significantly reduces the
amount of computation needed for each random step. A further speedup is achievable if we
constrain the maximum number of parents each vertex can have, either by using the same
fixed number for all nodes, or by pre-selecting a variable number of potential parents for
each node using, for instance, a preliminary L1-regularisation step [75].
Two DAGs are called Markov equivalent if they result in the same PDF [74]. Clearly, using
gene expression data alone, Bayesian networks can only be resolved up to Markov equiva-
lence. To break this equivalence and uncover a more specific causal gene regulation network,
genotype data is incorporated in the model inference process. The most straightforward
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approach is to use any of the methods in the previous section to calculate the probability
P(Xi → Xj) of a causal interaction from Xi to Xj [63,76–78], for example by defining the prior
as p(G) = ∏Xi
(
∏Xj∈Pa(G)(Xi) P(Xj → Xi)∏Xj 6∈Pa(G)(Xi)(1− P(Xj → Xi))
)
. A more ambitious
approach is to jointly learn the eQTL associations and causal trait (i.e. gene or phenotype)
networks. In [79], EM is used to alternatingly map eQTLs given the current DAG structure,
and update the DAG structure and model parameters given the current eQTL mapping.
In [80], Bayesian networks are learned where SNPs and traits both enter as variables in the
model, with the constraint that traits can depend on SNPs, but not vice versa. However, the
additional complexity of both methods means that they are computationally expensive and
have only been applied to problems with a handful of traits [79, 80].
A few additional “tips and tricks” are worth mentioning:
• First, when the number of vertices is much larger than the sample count, we may
break the problem into independent sub-problems by learning a separate Bayesian
network for each co-expression module (Section 3.1 and [78]). Dependencies between
modules could then be learned as a Bayesian network among the module eigengenes
[81], although this does not seem to have been explored.
• Second, Bayesian network learning algorithms inevitably result in locally optimal mod-
els which may contain a high number of false positives. To address this problem, we
can run the algorithm multiple times and report an averaged network, only consisting
of edges which appear sufficiently frequent.
• Finally, another technique that helps in distinguishing genuine dependencies from
false positives is bootstrapping, where resampling with replacement is executed on the
existing sample pool. A fixed number of samples are randomly selected and then pro-
cessed to predict a Bayesian network. This process is repeated many times, essentially
regarding the distribution of sample pool as the true PDF, and allowing to estimate
the robustness of each predicted edge, so that only those with high significance are re-
tained [82]. In theory, even the whole pipeline of Figure 1 up to the in silico validation
could be simulated in this way. Although bootstrapping is computationally expensive
and mostly suited for small datasets, it could be used in conjunction with the separa-
tion into modules on larger datasets.
4.3 Using module networks to identify causal regulatory mechanisms
Module network inference is a statistically well-grounded method which uses probabilistic
graphical models to reconstruct modules of co-regulated genes and their upstream regula-
tory programs, and which has been proven useful in many biological case studies [61,83,84,
105]. The module network model was originally introduced as a method to infer regulatory
networks from large-scale gene expression compendia, as implemented in the Genomica
software (http://genomica.weizmann.ac.il) [83]. Subsequently the method has been ex-
tended to integrate eQTL and gene expression data [52, 85, 86]. The module network model
starts from the same formula as Equation (2). It is then assumed that genes belonging to
the same module share the same parents and conditional distributions; these conditional
distributions are parameterized as decision trees, with the parental genes on the internal
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(decision) nodes and normal distributions on the leaf nodes [83]. Recent algorithmic in-
novations decouple the module assignment and tree structure learning from the parental
gene assignment and use Gibbs sampling and ensemble methods for improved module net-
work inference [60, 87]. These algorithms are implemented in the Lemon-Tree software
(https://github.com/eb00/lemon-tree), a command line software suite for module net-
work inference [61].
4.4 Illustrative example
We have recently identified genome-wide significant eQTLs for 6,500 genes in seven tissues
from the Stockholm Atherosclerosis Gene Expression (STAGE) study [12], and performed
co-expression clustering and causal networks reconstruction [88]. To illustrate the above
concepts, we show some results for a co-expression cluster in visceral fat (88 samples, 324
genes) which was highly enriched for tissue development genes (P = 5× 10−10) and con-
tained 10 genome-wide significant eQTL genes and 25 transcription factors, including eight
members of the homeobox family (Figure 2a).
A representative example of an inferred causal interaction is given by the co-expression
interaction between HAP1 (huntingtin-associated protein 1, chr17 q21.2-21.3) and FOXG1
(forkhead box G1, chr14 q11-q13). The expression of both genes is highly correlated (ρ =
0.85, P = 4.4× 10−24, Figure 2b). HAP1 expression shows a significant, non-linear associ-
ation with its eQTL rs1558285 (P = 1.2× 10−4); this SNP also associates significantly with
FOXG1 expression in the cross-association test (P = 0.0024), but not anymore after con-
ditioning FOXG1 on HAP1 and its own eQTL rs7160881 (P = 0.67) (Figure 2c). In contrast,
although FOXG1 expression is significantly associated with its eQTL rs7160881 (P = 0.0028),
there is no association between this SNP and HAP1 expression (P = 0.037), and condition-
ing on FOXG1 and HAP1’s eQTL has only a limited effect (P = 0.19) (Figure 2d). Using
conditional independence tests (Section 4.1), this results in a high-confidence prediction that
HAP1→ FOXG1 is causal.
A standard greedy Bayesian network search algorithm [75] was run on the aforementioned
cluster of 324 genes. Figure 2e shows the predicted consensus sub-network of causal inter-
actions between the 10 eQTLs and 25 TFs. This illustrates how a sparse Bayesian network
can accurately represent the fully connected co-expression network (all 35 genes have high-
mutual co-expression, cf. Figure 2a).
Figure 2f shows a typical regulatory module inferred by the Lemon-Tree software, also from
the STAGE data. Here a heatmap is shown of the genotypes of an eQTL (top), the expres-
sion levels of a regulatory gene (middle), predicted to regulate a co-expression module of 11
genes (bottom). The red lines indicate sample clusters representing separate normal distri-
butions inferred by the model-based co-clustering algorithm (Section 3.2).
5 In silico validation of predicted gene regulation networks
Gene regulation networks reconstructed from omics data represent hypotheses about the
downstream molecular implications of genetic variations in a particular cell or tissue type.
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Figure 2: (a) Heatmap of standardized expression profiles across 88 visceral fat samples
for 10 eQTL genes and 25 TFs belonging to a co-expression cluster inferred from the STAGE
data. (b) Co-expression of HAP1 and FOXG1 across 88 visceral fat samples. (c) Association
between HAP1’s eQTL (rs1558285) and expression of HAP1 (red), FOXG1 (blue) and FOXG1
adjusted for HAP1 and FOXG1’s eQTL (green). (d) Association between FOXG1’s eQTL
(rs7160881) and expression of FOXG1 (blue), HAP1 (red), and HAP1 adjusted for FOXG1
and HAP1’s eQTL (green). (e) Causal interactions inferred between the same genes as in (a)
using Bayesian network inference. (f) Example of a regulatory module inferred by Lemon-
Tree from the STAGE data. See Section 4.4 for further details.
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An essential first step towards using these networks in concrete applications (e.g. discov-
ering novel candidate drug target genes and pathways) consists of validating them using
independent data. The following is a non-exhaustive list of typical in silico validation exper-
iments.
Model likelihood comparison and cross-validation. When different algorithms are used
to infer gene network models, their log-likelihoods can be compared to select the best one.
(With the caveat that the same data that was used to learn the models is used to compare
them, this comparison is meaningful only when the algorithms optimize exactly the same
(penalized) log-likelihood functions.) In a K-fold cross-validation experiment, the available
samples are divided into K subsets of approximately equal size. For each subset, models
are learned from a dataset consisting of the K− 1 other subsets, and the model likelihood is
calculated using only the unseen data subset. Thus, cross-validation is used to test the gen-
eralisability of the inferred network models to unseen data. For an example where model
likelihood comparison and cross-validation were used to compare two module network in-
ference strategies, see [87].
Functional enrichment. Organism-specific gene ontology databases contain structured func-
tional gene annotations [89]. These databases can be used to construct gene signature sets
composed of genes annotated to the same biological process, molecular function or cellu-
lar component. Reconstructed gene networks can then be validated by testing for enriched
connectivity of gene signature sets using a method proposed by [76]. For a given gene set,
this method considers all network nodes belonging to the set and their nearest neighbours,
and from this set of nodes and edges, the largest connected sub-network is identified. Then
the enrichment of the gene set in this sub-network is tested using the Fisher exact test and
compared to the enrichment of randomly selected gene sets of the same size.
Comparison with physical interaction networks. Networks of transcription factor - tar-
get interactions based on ChIP-sequencing data [90] from diverse cell and tissue types are
available from the ENCODE [91], Roadmap Epigenomics [92] and modENCODE [93–95]
projects, while physical protein-protein interaction networks are available for many organ-
isms through databases such as the BioGRID [96]. Due to indirect effects, networks pre-
dicted from gene expression data rarely show a significant overlap with networks of direct
physical interactions. A more appropriate validation is therefore to test for enrichment for
short connection paths in the physical networks between pairs predicted to interact in the
reconstructed networks [61].
Gene perturbation experiments. Gene knock-out experiments provide the ultimate gold
standard of a causal network intervention, and genes differentially expressed between knock-
out and control experiments can be considered as true positive direct or indirect targets of
the knocked-out gene. Predicted gene networks can be validated by compiling relevant (i.e.
performed in a relevant cell or tissue type) gene knock-out experiments from the Gene Ex-
pression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) or ArrayExpress (https://www.
ebi.ac.uk/arrayexpress/) and comparing the overlap between gene sets responding to a
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gene knock-out and network genes predicted to be downstream of the knocked-out gene.
Overlap significance can be estimated by using randomized networks with the same degree
distribution as the predicted network.
6 Future perspective: Integration of multi-omics data
Although combining genotype and transcriptome data to reconstruct causal gene networks
has led to important discoveries in a variety of applications [21], important details are not
incorporated in the resulting network models, particularly regarding the causal molecu-
lar mechanisms linking eQTLs to their target genes, and the relation between variation in
transcript levels and protein levels, with the latter ultimately determining phenotypic re-
sponses. Several recent studies have shown that at the molecular level, cis-eQTLs primarily
cause variation in transcription factor binding to gene regulatory DNA elements, which then
causes changes in histone modifications, DNA methylation and mRNA expression of nearby
genes (reviewed in [15]). Although mRNA expression can be used as a surrogate for pro-
tein expression, due to diverse post-transcriptional regulation mechanisms, the correlation
between mRNA and protein levels is known to be modest [97,98], and genetic loci that affect
mRNA and protein expression levels do not always overlap [28, 99]. Thus, an ideal systems
genetics study would integrate genotype data and molecular measurements at all levels of
gene regulation from a large number of individuals.
Human lymphblastoid cell lines (LCL) are emerging as the primary model system to test
such a approach. Whole-genome mRNA and micro-RNA sequencing data are available for
462 LCL samples from five populations genotyped by the 1000 Genomes Project [35]; pro-
tein levels from quantitative mass spectrometry for 95 samples [99]; ribosome occupancy
levels from sequencing of ribosome-protected mRNA for 50 samples [100]; DNA-occupancy
levels of the regulatory TF PU.1, the RNA polymerase II subunit RBP2, and three histone
modifications from ChIP-sequencing of 47 samples [101]; and the same three histone mod-
ifications from ChIP-sequencing of 75 samples [102]. These population-level datasets can
be combined further with three-dimensional chromatin contact data from Hi-C [103] and
ChIA-PET [102], knock-down experiments followed by microarray measurements for 59
transcription-associated factors and chromatin modifiers [104], as well as more than 260
ENCODE assays (including ChIP-sequencing of 130 TFs) [91] in a reference LCL cell line
(GM12878). Although the number of samples where all measures are simultaneously avail-
able is currently small, this number is sure to rise in the coming years, along with the avail-
ability of similar measurements in other cell types. Despite the challenging heterogeneity
of data and analyses in the integration of multi-omics data, web-based toolboxes, such as
GenomeSpace (http://www.genomespace.org) [105] can prove helpful to non-programmer
researchers.
7 Conclusions
In this chapter we have reviewed the main methods and softwares to carry out a systems
genetics analysis, which combines genotype and various omics data to identify eQTLs and
their associated genes, reconstruct co-expression networks and modules, reconstruct causal
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Bayesian gene and module networks, and validate predicted networks in silico. Several
method and software options are available for each of these steps, and by necessity a sub-
jective choice about which ones to include had to be made, based largely on their ability
to handle large datasets, their popularity in the field, and our personal experience of using
them. Where methods have been compared in the literature, they have usually been per-
formed on a small number of datasets for a specific subset of tasks, and results have rarely
been conclusive. That is, although each of the presented methods will give somewhat dif-
ferent results, no objective measurements will consistently select one of them as the “best”
one. Given this lack of objective criterion, the reader may well prefer to use a single software
that allows to perform all of the presented analyses, but such an integrated software does
not currently exist.
Nearly all of the examples discussed referred to the integration of genotype and transcrip-
tome data, reflecting the current dominant availability of these two data types. However,
omics technologies are evolving at a fast pace, and it is clear that data on the variation of TF
binding, histone modifications, and post-transcriptional and protein expression levels will
soon become more widely available. Developing appropriate statistical models and compu-
tational methods to infer causal gene regulation networks from these multi-omics datasets
is surely the most important challenge for the field.
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